Proliferation marker Ki-S11--a prognostic indicator for squamous cell carcinoma of the hypopharynx

Virchows Arch. 1999 Dec;435(6):590-5. doi: 10.1007/s004280050445.

Abstract

As a potential prognostic factor, the proliferative activity of 131 squamous cell carcinomas (SCC) of the hypopharynx and 47 of their cervical lymph-node metastases was analyzed retrospectively by means of monoclonal antibody Ki-S11 immunostaining, which specifically detects the Ki-67 antigen on paraffin-embedded tissue. Median follow-up time was 37.6 months. Ki-S11 revealed distinctive patterns of proliferating cells related to the degree of differentiation. The proliferation fractions in the primaries and their lymph-node metastases did not differ significantly. Patients with high proliferating hypopharynx carcinomas (>45% labeled cells) had a significantly lower 5-year-survival rate (16%) than patients with low proliferating tumors, whose 5-year-survival rate was 30% (P=0.01). A statistically significant positive correlation was also observed between proliferative activity and lymph-node status (P=0.012). In conclusion, the proliferative activity as determined by means of Ki-S11 immunostaining is of prognostic value with respect to both survival and metastatic risk in SCC of the hypopharynx.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal
  • Carcinoma, Squamous Cell / diagnosis*
  • Carcinoma, Squamous Cell / metabolism*
  • Carcinoma, Squamous Cell / mortality
  • Cell Division
  • Cell Nucleus / metabolism
  • Cell Nucleus / pathology
  • Cohort Studies
  • Female
  • Humans
  • Hypopharyngeal Neoplasms / diagnosis*
  • Hypopharyngeal Neoplasms / metabolism*
  • Hypopharyngeal Neoplasms / mortality
  • Immunoenzyme Techniques
  • Ki-67 Antigen / metabolism*
  • Lymph Nodes / pathology
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Prognosis
  • Survival Rate

Substances

  • Antibodies, Monoclonal
  • Ki-67 Antigen